# System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2

> **NCT03523663** · — · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 46 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder

## Interventions

- **OTHER:** no intervention. measure eye movement data

## Key facts

- **NCT ID:** NCT03523663
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-01
- **Primary completion:** 2019-09-11
- **Final completion:** 2019-09-11
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** difficulty recruiting pediatric participants followed by a prolonged shut down due to COVID-19
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03523663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03523663, "System for Determining Ideal Drug Doses for ADHD - Stages 1 and 2". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03523663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*